Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 20 Sep 2022 |
2 | Reply to Exam Report (MIS-R) | 13 Apr 2023 |
3 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 02 Apr 2024 |
4 | TM-O(NOTICE OF OPPOSITION) | 03 Aug 2024 |
5 | Journal Copy | 20 Aug 2024 |
6 | TM-O(NOTICE OF OPPOSITION) | 24 Oct 2024 |
1 | EXAMINATION REPORT | 15025468 | 28 Mar 2023 | |
2 | Hearing Notice (Show Cause) | 17605967 | 04 Mar 2024 | |
3 | Hearing Notice (Show Cause) | 18178063 | 17 May 2024 | |
4 | Tribunal Accepted Notice for : 5616965 | 18431661 | 6793879 | 03 Jul 2024 |
5 | Opposition Notice | 18879172 | 6913313 | 20 Sep 2024 |
The application for Enclone was made on 20 September 2022.
The trademark applicant for Enclone is BIOLOGICAL E.
Enclone is applied in class(es) 5.
Application for Enclone is on Opposed stage.
Application Id allotted to Enclone is 5616965.
Trademark agent or attorney for the application is Kayser And Company.
Enclone filed with the Intellectual property office as a WORD.